MXPA03001607A - Nuevos macrolidos con actividad antibacteriana. - Google Patents

Nuevos macrolidos con actividad antibacteriana.

Info

Publication number
MXPA03001607A
MXPA03001607A MXPA03001607A MXPA03001607A MXPA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A
Authority
MX
Mexico
Prior art keywords
antibacterial activity
new macrolides
heterocyclyl
hydrogen
formula
Prior art date
Application number
MXPA03001607A
Other languages
English (en)
Spanish (es)
Inventor
Peter Angehrn
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of MXPA03001607A publication Critical patent/MXPA03001607A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MXPA03001607A 2000-08-22 2001-08-20 Nuevos macrolidos con actividad antibacteriana. MXPA03001607A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00117971 2000-08-22
PCT/EP2001/009560 WO2002016380A1 (en) 2000-08-22 2001-08-20 New macrolides with antibacterial activity

Publications (1)

Publication Number Publication Date
MXPA03001607A true MXPA03001607A (es) 2003-06-04

Family

ID=8169600

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001607A MXPA03001607A (es) 2000-08-22 2001-08-20 Nuevos macrolidos con actividad antibacteriana.

Country Status (14)

Country Link
US (1) US6740642B2 (enExample)
EP (1) EP1313751B1 (enExample)
JP (1) JP4162992B2 (enExample)
KR (1) KR100502031B1 (enExample)
CN (1) CN1234718C (enExample)
AT (1) ATE408614T1 (enExample)
AU (1) AU2001282105A1 (enExample)
BR (1) BR0113472A (enExample)
CA (1) CA2419296C (enExample)
DE (1) DE60135859D1 (enExample)
ES (1) ES2313975T3 (enExample)
MX (1) MXPA03001607A (enExample)
WO (1) WO2002016380A1 (enExample)
ZA (1) ZA200301047B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2275621T3 (es) * 2000-12-21 2007-06-16 Glaxo Group Limited Antibioticos macrolidos.
FR2826274B1 (fr) * 2001-06-21 2003-09-26 Aventis Pharma Sa Formulation pharmaceutique au gout masque et son procede de preparation
CN1589277A (zh) * 2001-09-17 2005-03-02 奥索-麦克尼尔药品公司 6－o－氨基甲酸酯－11,12－内酯－酮内酯抗菌剂
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) * 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
US6720308B1 (en) 2002-11-07 2004-04-13 Enanta Pharmaceuticals, Inc. Anhydrolide derivatives having antibacterial activity
US6716820B1 (en) 2003-06-05 2004-04-06 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic macrolides
US20040254126A1 (en) * 2003-06-05 2004-12-16 Yao-Ling Qiu 11-12 Bicyclic erythromycin derivatives
US6790835B1 (en) 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US6774115B1 (en) 2003-06-05 2004-08-10 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic ketolides
WO2004108745A2 (en) * 2003-06-05 2004-12-16 Enanta Pharmaceuticals, Inc. 11-12 bicyclic erythromycin derivatives
US6765016B1 (en) 2003-06-05 2004-07-20 Enanta Pharmaceuticals, Inc. Bicyclic ketolide derivatives
WO2006065721A2 (en) * 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
DE602006006030D1 (de) * 2005-02-09 2009-05-14 Basilea Pharmaceutica Ag Neue makrolide
CN101115764B (zh) * 2005-02-09 2012-09-26 巴斯利尔药物股份公司 大环内酯类化合物
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
JP2009506066A (ja) 2005-08-24 2009-02-12 リブ−エックス ファーマシューティカルズ，インコーポレイテッド トリアゾール化合物ならびにこれを作製する方法および使用する方法
PT2049556E (pt) * 2006-08-09 2013-08-22 Basilea Pharmaceutica Ag Novos macrólidos úteis contra doenças inflamatórias e alérgicas
EP2056844A4 (en) * 2006-08-24 2010-11-24 Wockhardt Research Center NEW MACROLIDS AND KETOLIDS WITH ANTIMICROBIAL EFFECT
CN101939327B (zh) * 2008-02-08 2015-03-11 巴斯利尔药物股份公司 新的大环内酯类及其用途
JP5769972B2 (ja) * 2008-02-08 2015-08-26 バジリア ファルマスーチカ アーゲーＢａｓｉｌｅａ Ｐｈａｒｍａｃｅｕｔｉｃａ ＡＧ Ｐｄｅ阻害により仲介される疾患を処置するためのマクロライド
RU2011153353A (ru) * 2009-05-27 2013-07-10 Вокхардт Рисерч Сентер Кетолидные соединения, обладающие противомикробной активностью
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
CN102417530A (zh) * 2010-09-26 2012-04-18 中国医学科学院药物研究所 广谱抗菌素红霉素a大环酮内酯类衍生物的合成方法和用途
EP3216798A3 (en) 2010-12-09 2017-10-25 Wockhardt Limited Ketolide compounds
US9206214B2 (en) 2011-03-01 2015-12-08 Wockhardt Ltd. Process for preparation of ketolide intermediates
PL2938623T3 (pl) * 2012-12-31 2017-03-31 Basilea Pharmaceutica Ag Wybrane makrolidy o działaniu hamującym pde4
US10857171B2 (en) 2016-01-12 2020-12-08 Wockhardt Limited Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
DE60135859D1 (de) 2008-10-30
AU2001282105A1 (en) 2002-03-04
EP1313751A1 (en) 2003-05-28
CN1234718C (zh) 2006-01-04
CA2419296C (en) 2008-12-09
ES2313975T3 (es) 2009-03-16
JP2004506740A (ja) 2004-03-04
ATE408614T1 (de) 2008-10-15
CA2419296A1 (en) 2002-02-28
KR20030029839A (ko) 2003-04-16
KR100502031B1 (ko) 2005-07-25
WO2002016380A1 (en) 2002-02-28
US20030199459A1 (en) 2003-10-23
JP4162992B2 (ja) 2008-10-08
BR0113472A (pt) 2003-07-01
ZA200301047B (en) 2004-05-06
US6740642B2 (en) 2004-05-25
EP1313751B1 (en) 2008-09-17
CN1464880A (zh) 2003-12-31

Similar Documents

Publication Publication Date Title
BR0113472A (pt) Macrolìdeos com atividade antibacteriana
HK1046688A1 (zh) 喹唑啉化合物和含有喹唑啉化合物的藥物組合物
FR2742757B1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CA2284732A1 (en) Analogs of cocaine
ATE541576T2 (de) 2'-o,4'-c-methylen bicyclonukleoside
EP1036794A4 (en) 2-ARYL-8-OXODIHYDROPURIN DERIVATIVES, THEIR PRODUCTION, THEIR USE AS MEDICINE COMPONENTS AND THEIR INTERMEDIATES
CA2476884A1 (en) Macrolides with antibacterial activity
YU50002A (sh) Supstituisani piperidini, lekovi koji sadrže ova jedinjenja i postupci za njihovu proizvodnju
AU2001232287A1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both
YU14003A (sh) Biciklična heterociklična jedinjenja, lekovi koji sadrže ova jedinjenja, njihova primena i postupak za njihovo dobijanje
AU2001295482A1 (en) Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
IL145005A0 (en) 4-OXO-4, 7-DIHYDRO-THIENO[2,3-b] PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS
ATE231143T1 (de) Triarylimidazole
WO2004108664A3 (de) Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
DE69907419D1 (en) Antitumorwirkstoffe
WO1999004770A3 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
HRP930014A2 (en) 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2804958B1 (fr) Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
WO2000078956A8 (en) Novel pyrrhocoricin-derived peptides, and methods of use thereof
EP0497978A4 (en) Cephalosporin compounds and production thereof
ZA200108484B (en) Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin A.
WO2001030328A3 (de) Verwendung von 2-amino-3,4-dihydro-chinazolinen zur herstellung eines medikaments zur behandlung oder prophylaxe von durch ischämischen zuständen bewirkten krankheiten
AU2003282256A1 (en) Substituted 9a-n-{n'-(4-(sulfonyl)phenyl)carbamoyl} derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithromycin a and 5-0-desosaminyl--9-deoxo-9-di-hydro-9a-aza-9a-homoerithronolide a
EP0254582A3 (en) 6 beta-(alpha-oximino)-acylamino penicillanic-acid derivatives and starting compounds

Legal Events

Date Code Title Description
FG Grant or registration